Dexcom | DXCM - 营业利润

股票价格
71.42
每天变化
-0.02 -0.03%
每月一次
12.63%
每年
-15.81%
Q2 预测
60.39


金融业
股票价格
USD
资产
USD 6.63B
现金及等价物
USD 1.12B
销售成本
USD 441.6M
流动资产
USD 4.33B
流动负债
USD 2.22B
债务
USD 1.24B
EBIT
USD 255.3M
EBITDA
USD 364.5M
员工
10.3K
EPS每股收益
USD 0.56
股本和储备
USD 2.96B
销售毛利
USD 750.3M
债务利息支出
USD 4.2M
利息收入
USD 23.5M
贷款资金
USD 1.3B
市值
USD 27.79B
净收入
USD 199.5M
营业费用
USD 936.6M
营业利润
USD 255.3M
普通股股本
USD 385.9M
PE价格收益
24.73
税前利润
USD 340.7M
销售收入
USD 1.19B
销售和管理费用
USD 349.7M
股票
USD 693.6M
贸易债权人
USD 1.94B
应收帐款人
USD 1.09B


营业利润 更改 日
Abbott USD 1.85B 399M 2026-03
Align Technology USD 178.05M 46.66M 2026-03
AtriCure USD 526K 1.96M 2026-03
Avanos Medical USD 8.9M 15.87M 2026-03
Baxter International USD 66M 280.2M 2026-03
Becton, Dickinson and Co. USD 627M 36M 2026-03
Boston Scientific USD 1.05B 190M 2026-03
Cooper Companies USD 212.8M 72.4M 2025-12
Dexcom USD 255.3M 67.7M 2026-03
Edwards Lifesciences USD 514.7M 144.4M 2026-03
Globus Medical USD 164M 17.31M 2026-03
Inogen USD -7.79M 728K 2024-09
Insulet USD 122M 24.3M 2026-03
Integra LifeSciences USD 11.47M 54.54M 2026-03
J&J USD 6.62B 1.03B 2026-03
Masimo USD 77.4M 6.5M 2026-03
Medtronic USD 1.74B 40M 2025-12
Merit Medical Systems USD 44.16M 10.04M 2026-03
Roche Holding CHF 9.56B 3.8B 2025-12
Solventum Corp USD 85M 20M 2026-03
Stryker USD 1.1B 867M 2026-03
Tandem Diabetes Care USD 8.29M 31.16M 2025-12
Teleflex USD 37.03M 686K 2026-03
West Pharmaceutical Services USD 177.1M 14.6M 2026-03
Zimmer Biomet Holdings USD 395.1M 92.2M 2026-03